METTL14 and renal cell adenocarcinoma: These results are consistent with a previous study [32]: Jiawu Wang indicated most of the m6A regulators have different expressions in RCC tissue, and METTL14 and METTL3 were identified as two powerful independent prognostic regulators after further analysis.